Regarding to MDA-MB-231 TS cells, we did not see a significant increase in the CD44+/CD24− subpopulation, however the percentage in all groups was very high, around 80%, which is in concordance with the highly invasive/metastatic skills of this triple negative breast cancer cell line29. This evidence concerns the gene CD44 and triple-negative breast carcinoma.